Shingo Yano
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 200 publications
Aplastic anemia developed after treatment with durvalumab
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: August 23, 2026
JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: July 01, 2026
Plasmablastic lymphoma through clonal expansion 17 years after EBV-positive DLBCL: case report and review.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: May 31, 2026
Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.
Journal: Transplantation and cellular therapy
Published: May 25, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.
Journal: Blood advances
Published: May 05, 2026
Schlafen 11 (SLFN11) overexpression and nucleolar localization in response to bortezomib in multiple myeloma.
Journal: bioRxiv : the preprint server for biology
Published: April 29, 2026
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.
Journal: International journal of clinical oncology
Published: April 11, 2026
Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease.
Journal: Drug discoveries & therapeutics
Published: April 01, 2026
Schlafen 11 (SLFN11) is overexpressed in multiple myeloma and undergoes nucleolar translocation in response to bortezomib.
Journal: Cancer research communications
Published: February 25, 2026
Voriconazole versus itraconazole for antifungal prophylaxis in patients with graft-versus-host disease: A prospective randomized trial.
Journal: International journal of hematology
Published: February 17, 2026
Maintenance Treatment With Gilteritinib Suppresses Post-transplant Relapse in Relapse/Refractory FLT3-Mutated Acute Myeloid Leukemia.
Journal: Transplantation and cellular therapy
Published: February 14, 2026
Last Updated: 09/26/2026